AT
CANO

Arlington Trust’s Cano Health, Inc. CANO Stock Holding History

Arlington Trust’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$23 – 927
2023
Q4 		$23 Buy
+4
New +$47 ﹤0.01% 906

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Arlington Trust's CANO Position: Q1 2024 in Review

Arlington Trust sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 4 shares — an estimated $23 sold.

Arlington Trust first reported a position in CANO in Q4 2023 and held it in 1 quarter. The position peaked at $23 in Q4 2023. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Arlington Trust reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Arlington Trust sold 4 Cano Health, Inc. shares in Q1 2024, an estimated $23.
  • Arlington Trust first reported a position in Cano Health, Inc. in Q4 2023 and held it in 1 quarter.
  • Arlington Trust's Cano Health, Inc. position peaked at $23 in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.